Replies to post #712 on Resverlogix Corp. (RVXCF)

[noretreat]

I agree it shows a definite pattern. In my experience, as soon as the chart is "figured out" it changes.

We are nearing an announcement of 250 MACE events in the Apabetalone trial. Probably by end of year. That will come about 2 months in front of topline data. Hang on to your hats at that point.